The ability to reduce Hg(II) to Hg(0), which is determined by a plasmid-borne gene in Escherichia coli, is conferred by a Hg(II)-inducible activity which is located in the cytoplasm rather than in the periplasmic space of the cell. This Hg(II)-reducing activity can be isolated from the supernatant of a 160,000 x g centrifugation after French Press disruption of the cells. The activity is dependent on glucose-6-phosphate, glucose-6-phosphate dehydrogenase, and 2-mercaptoethanol, but is not enhanced by added nicotinamide adenine dinucleotide phosphate. Treatment of the active fraction with N-ethylmaleimide causes irreversible loss of the Hg(II)-reducing activity. Unlike the Hg(Il)-reducing activity found in intact cells, the cell-free activity is not inhibited by toluene, potassium cyanide, or m-chlorocarbonylcyanide-phenylhydrazone; however, it is inhibited by Ag(I) and phenylmercuric acetate to the same extent as the activity in intact cells. Neither phenylmercuric acetate nor methylmercuric chloride is reduced to Hg(0) by the cell-free activity. Au(III), however, is a substrate for the cell-free activity; it is reduced to metallic colloidal Au(0).
Two modes of interaction of bacteria with mercury-containing compounds have been the subject of several recent studies (1-3, 6, 7, 13-17) . The ability to methylate Hg(II) is found in several anaerobic species, including Methanobacter (15) and Clostridia (16, 17) . These bacteria effect a non-enzymatic transfer of a methyl group from methylcobalamine to Hg(II). On the other hand, several aerobic or facultative species have been shown to reduce inorganic and organic mercury compounds to metallic mercury via a mechanism which is inducible by mercuric or mercurial compounds. Bacteria using this mechanism to eliminate mercury from their environment include Escherichia coli (6, 7, 13, 14) , Staphylococcus aureus (13) , and several species of Pseudomonas (1) (2) (3) 13) . In the E. coli and S. aureus strains and in some Pseudomonas strains, the genes determining the ability to reduce Hg(II) have been shown to map on plasmids or resistance factors (R factors).
This report describes a cell-free Hg(ll)-reducing activity from a Hg(II) -resistant R factor-carrying strain of E. coli.
MATERIALS AND METHODS
Bacterial strains. E. coli AB1932-1(JJ1), a K-12 strain carrying the mercury-resistant plasmid, has a Present address: Department of Microbiology, University of Virginia. School of Medicine, Charlottesville, Va. 22901 been described (5, 14) . E 
RESULTS
Cellular location of the Hg(II)-reducing activity. It has been reported that in enteric bacteria, the R factor-determined penicillinases (10) and the streptomycin-adenylating enzyme are located in the periplasmic space and that the R factor-determined chloramphenicol acetyl transferase is a cytoplasmic enzyme (12) . To determine whether the Hg(II)-reducing activity is present in the cytoplasm, the periplasm, or both, we examined the distribution of Hg(II) -reducing activity in induced resistant cells that were converted to spheroplasts and then lysed. For these experiments Hg(II)-induced AB1932-l(JJ1) cells were mixed 1:1 with K1OC4 cells that are constitutive for the synthesis of alkaline phosphatase, an enzyme known to be located in the periplasmic space (11) , and that had been induced with isopropylthiogalactoside for the synthesis of beta-galactosidase, a cytoplasmic enzyme (11) . To correlate the mercuryreducing activity with either the cytoplasmic or periplasmic space (as defined by the distribution of the K1OC4 enzymes) we assumed that these two strains of E. coli K-12 were similarly sensitive to spheroplasting.
All of the Hg(II)-reducing activity was present in the intact spheroplasts rather than in their supernatant fluid, whereas all of the alkaline phosphatase was released into the supematant fluid of the spheroplasts (Table 1) . Because alkaline phosphatase is one of the (Table 2 ). This isolation method differs from that described for a Hg(II)-reducing activity from E. coli that was used by Komura et al. (7) and from that for a Hg(II)-and organomercurialreducing activity from a Pseudomonas species which was used by Furukawa and Tonomura (1) (2) (3) . We found that we could only recover 20 to 30% of the activity after ammonium sulfate fractionation, as described by both of the above groups. This was true even though the assay medium contained all of the cofactors which these other systems have been shown to require, including reduced nicotinamide adenine dinucleotide phosphate (NADPH), flavine Requirements for the activity of the vacuum-dialyzed S160. Only glucose-6-phosphate, glucose-6-phosphate dehydrogenase, and 2-mercaptoethanol are necessary for full activity in the cell-free system (Table 3 and Fig. 1 ). Neither NADP+, FAD, nor cytochrome c enhance the activity at this stage of purification. As noted above, these reagents were examined because the Hg(II)-reducing activity in another strain of E. coli has been shown to require NADPH (7) and a Hg(II)-and mercurialreducing activity in a Pseudomonas has been shown to require NADPH, FAD, and a c-type cytochrome (1-3) . The vacuum-dialyzed S160, which has been boiled for 3 min, is not active even with complete assay medium, as described 50 ,uM restores only about 30% of the maximum activity assayable with 0.5 mM 2-mercaptoethanol.
Incubation of the vacuum dialyzed S160 at pH 8.1 for 15 min at 24 C in the same series of 2-mercaptoethanol concentrations as in Fig. 1 followed by a 100-fold dilution into assay medium, complete except for 2-mercaptoethanol, resulted in a retention of only 5 to 20% of the activity (data not shown). There are two possible explanations of this requirement for a sulfhydryl compound: either there is a very rapidly oxidizable sulfhydryl group on a protein that is involved in the reducing activity; or it may be that the real substrate in the reaction is mercurated 2-mercaptoethanol. This latter possibility must be considered because in the 100-fold molar excess of 2-mercaptoethanol in which the assay is done, essentially no free Hg2+ cation will be present; unreduced mercury in this assay medium will be present almost entirely as the mercaptide derivative.
The two possibilities for the role of a sulfhydryl compound are not mutually exclusive. To test the first possibility we asked whether there was a protein-bound sulfhydryl group necessary for the activity in the vacuum-dialyzed S160. The vacuum-dialyzed S160 was thoroughly reduced with an excess of 2-mercaptoethanol at pH 8.1, and then the sulfhydryl groups present were exposed to the alkylating reagent, N-ethylmaleimide (NEM). The data in Table 4 show that treatment with sufficient NEM to saturate completely the sulfhydryl groups present destroys the activity. Incubation with 2-mercaptoethanol at pH 8.1 followed by exposure to a less-than-saturating concentration of NEM caused no loss of activity at all. We therefore believe that there is a protein-bound sulfhydryl group that is subject to alkylation by NEM and that is essential for the activity. The possibility that 2-mercaptoethanol is also required to form a Hg-mercaptide which is the recognized substrate remains to be tested.
Inhibitors of the cell-free activity. Several of the inhibitors which had been used to exam- a Preparations A and B were both prepared as described in Materials and Methods. Preparation A had been stored at 4 C for 1 week when the above experiment was done; preparation B was freshly prepared.
b The vacuum-dialyzed S160 was diluted 1: 1 with 2 mM 2-mercaptoethanol in 0.1 M Tris-hydrochloride, pH 8.1, and incubated at 24 C for 10 min. A 20-gliter portion of this reduced vacuum-dialyzed S160 was then added to 0.1 ml of either 0.5 mM or 2.0 mM NEM in 50 mM sodium phosphate buffer, pH 7.0, containing 0.75 mM 2-mercaptoethanol, and incubated at 24 C for 15 min. A 5-gliter portion of this NEM-treated vacuum-dialyzed S160 was then diluted into 0.5 ml of assay medium supplemented with FAD and cytochrome c, each at 1 gM, and assayed for Hg(II)-reducing activity as described in Materials and Methods.
ine this activity in whole cells (14) were examined for their effect on the cell-free activity ( Table 5 ). The inhibitor of the terminal oxidation of the electron transport chain, KCN, and the uncoupler of oxidative phosphorylation, m-chlorocarbonylcyanide-phenylhydrazone, do not inhibit the activity of the S160 fraction at the same levels which cause inhibition of the activity in whole cells. This suggests that there is some energy-dependent process necessary for Hg(II)-reducing activity in whole cells which is bypassed in the cell-free system.
The data on toluene inhibition of the activity in whole cells has been variable. Initial experiments showed clearly that exposure to 1% toluene (vol/vol) at 37 C did not affect the cells' ability to reduce successive additions of 10 ,uM HgCl2 (14) . Subsequent experiments showed a loss of 90% of the Hg(II)-reducing activity in whole cells after 8 min of exposure to 1% toluene at 37 C. However, it is clear from the data in Table 5 that exposure to toluene for approximately 8 min has no effect on the activity of the S160.
Both AgNO3 and phenylmercuric acetate in- 'A 5.0-gliter portion of the indicated material was added to duplicate 0.5-ml samples of the indicated medium containing the inhibitor at the indicated concentration at 4 C. These tubes were then warmed at 37 C for 5 min, and at time zero 10 Mliters of 0. hibit the activity of the S160 fraction to the same extent that they inhibit the activity in whole cells. We therefore examined more thoroughly the interaction of the cell-free activity with organomercurials with Ag(I) and with Au(III), which had also been shown to inhibit the activity in whole cells (14) .
Reaction with organomercurials. The mercury-reducing activity isolated by Furukawa and Tonomura from a Pseudomonas species will reduce not only Hg(II) but will also reduce various organomercurials, including methylmercuric chloride and phenylmercuric acetate, and release metallic mercury (1, 2) . We had examined the ability of whole cells of AB1932-l(JJ1) to release metallic mercury from methylmercuric chloride and found that they did not have this ability (14) . Therefore, by using both phenylmercuric acetate and methylmercuric chloride, labeled with 203Hg, we asked whether the S160 fraction prepared from AB1932-1(JJ1) could release metallic mercury from these compounds. Under conditions where we observe typical Hg(II)-reducing activity in the S160 fraction, there is essentially no release of metallic mercury by this preparation from either of the organomercurials (Table 6 ). Therefore, neither of these compounds will serve as a substrate for the Hg(II)-reducing activity in AB1932-1(JJ1).
Reaction with Ag(I) and Au(III). Both Ag(I) and Au(llI) salts markedly inhibited the Hg(ll)-reducing activity in whole cells (14) , and as shown above Ag(I) inhibits the cell-free activity (Table 5) . We have also found that mercury-resistant cells will bind four to six times more radioactive Ag(I) (added as 110mAg) TABLE 6 . Reaction of the S160 fraction with phenylmercuric acetate and methylmercuric chloridea per cell than sensitive cells. In the course of attempting to isolate the 110mAg-binding component from induced resistant cells, we noted that the dark colloid of silver metal was found in the presence of induced resistant cells much more rapidly than in the presence of sensitive cells or by the action of light alone. We subsequently found that this was also true for the formation of the dark purple colloid of gold metal from Au(III). This suggested that Ag(I) and possibly Au(III) were not only inhibitors of the Hg(II)-reducing activity but substrates for the reduction as well. We have encountered considerable technical difficulty in measuring directly the reduction of Ag(I) or Au(III). The difficulty arises primarily from the fact that the high concentration of protein in the case of whole cells, and the requirement of 1 mM 2-mercaptoethanol for the activity of the cellfree system, prevent efficient and reproducible partition of ionic and reduced forms of the metals by solvent-or resin-extraction techniques.
Currently the best measure of the interaction of the crude extract with these metal cations is the increase in optical density at 600 nm which occurs as the dark purple colloid of metallic gold is formed from Au(llI) in the presence of the vacuum-dialyzed S160 from induced AB1932-l(JJ1) (Fig. 2) . The background reduction of Au(III) by the assay medium alone which contains high concentrations of biological reducing agents is rather large, but the observation of more rapid and more extensive colloid formation by the vacuum-dialyzed S160 is consistently observable. Similar experiments with AgNOs show a change from a milky white suspension to a brown precipitate in the same period of time in the presence of the vacuumdialyzed S160. This suggests that both Au(llI) and Ag(I) will serve as substrates for this Hg(II)-reducing activity.
We have not examined the ability of the cell-free extract of sensitive cells to effect the formation of these colloidal metals; therefore, we cannot assert that this is a property of the cell-free extract of the induced resistant cells alone and not simply a result of some nonspecific interaction of cell proteins, the assay reagents, and Ag(I) or Au(EI) salts. We think it is very likely, however, because of the inability of sensitive cells to effect the formation of the colloidal metals, that this activity, like the Hg(ll)-reducing activity, is unique to the cellfree extract of the induced resistant cells. Formation of colloidal gold by the vacuumdialyzed S160. A 30-ml portion of crude extract was added to 3 ml of assay medium as described in Materials and Methods which was supplemented with 1 AM FAD and 1 AM cytochrome c and which contained 50 uM HAuCI4 rather than HgCI2. The reaction mixtures in covered 3-ml cuvets were incubated in a light-proof box at 37 C and their optical density at 600 nm was read periodically against a blank containing complete medium without HAuCI4 in a Beckman DB spectrophotometer. Dilutions of reactions with an optical density (600 nm) greater than 1.0 were made in deionized water. All manipulations were done in a dimly lit room. medium without HgCl2 and then, in late exponential phase, exposed to either HgCl2, HAuCl4, or Hg(II)-inducible R factor-determined Hg(ll))-reducing activity in a strain of E. coli. The cell-free activity prepared from this strain (28,000 x g supematant of sonicated cells) requires NADPH and a sulfhydryl compound. Furukawa and Tonomura have described a mercury-and mercurial-reducing activity in a strain of Pseudomonas (1-3). Nothing is as yet known about the genetics of this latter system. Unlike the activity we have investigated in E. coli, this system is inducible by and will reduce both Hg(II) and organomercurials, such as phenylmercuric acetate and methylmercuric chloride. The cell-free activity from Pseudomonas requires NADPH, cytochrome c, and a sulfhydryl compound and has a bound FAD.
The substrate specificity is perhaps the most outstanding of the differences in these three systems. We are currently examining phenylmercuric acetate-resistant and methylmercuric chloride-resistant strains of E. coli for their ability to reduce either of these compounds to metallic mercury. We would like to resolve the question of whether or not there are two distinct mechanisms of detoxification of mercurycontaining compounds in the enteric bacteria.
Mercury resistance occurs in 10 to 20% of the clinically isolated R factor-carrying strains of the enterics and in 20 to 30% of the resistance plasmid-carrying strains of the staphylococci (Frank Young, personal communication). The question of whether, and in what manner, these bacteria protect their hosts from heavy metals is an important one which is as yet unresolved. The existence of mercury detoxification systems in normal flora might provide a strategy for prophylaxis and/or treatment of humans and domestic animals accidentally or chronically exposed to high levels of mercury compounds.
The Hg(II) -reducing systems are interesting biochemically as well as ecologically. They constitute a new class of metabolic interaction with heavy metals. Such metals as cobalt, iron, nickel, molybdenum, and zinc have long been known to serve as co-catalysts in the activity of the metalloenzymes and the metal-ion activated enzymes. As catalysts they may be oxidized or reduced in a given reaction, but return to their original state when the reaction is completed. In addition to this widely found catalytic role of metals in metabolic processes, there is the narrower function of two metal cations, Fe(II) and Mn(ll), which serve as oxidizable substrates in the metabolism of the chemoautotrophic bacteria, such as the Thiobacilli and Metallogenium. These bacteria use the energy derived from the oxidation of these metals from the 2+ to the 3+ state to drive CO2 fixation and other metabolic processes. The mercury-reducing enzymes thus constitute a third class in which the metal ion substrate is reduced, and thereby detoxified, at the expense of metabolic energy.
The mercury-reducing enzymes in the enterics and staphylococci are plasmid determined, and, therefore, non-essential. They are, however, equipped with a Hg(ll)-specific induction mechanism and are therefore more "sophisticated" in their control than the constitutively synthesized antibiotic modifying enzymes. Each of these enzymes (and its respective control system) may have been derived by selection from an enzyme which occurs naturally in the cell complement to perform a different but closely related (enzymatically) function. The Hg(II)-reducing activity described in this report will be further purified in order to examine questions of both ecological and biochemical importance. LITERATURE CITED
